How to cite item

Neoadjuvant chemotherapy versus chemoradiotherapy for esophageal cancer: a tradeoff between dysphagia and pathologic response

   
@article{VATS4751,
	author = {Natalie Lui},
	title = {Neoadjuvant chemotherapy versus chemoradiotherapy for esophageal cancer: a tradeoff between dysphagia and pathologic response},
	journal = {Video-Assisted Thoracic Surgery},
	volume = {3},
	number = {0},
	year = {2018},
	keywords = {},
	abstract = {Sunde et al. reported their findings on the relief of dysphagia after neoadjuvant chemoradiotherapy versus chemotherapy in patients with esophageal cancer (1). Dysphagia was a secondary endpoint in a multicenter, randomized clinical trial, NEOadjuvant therapy in RESectable esophageal cancer (NeoRes) (2,3). They found that patients who underwent neoadjuvant chemoradiotherapy had higher rates of dysphagia, but a better pathologic response, compared to patients who underwent neoadjuvant chemotherapy.},
	issn = {2519-0792},	url = {https://vats.amegroups.org/article/view/4751}
}